Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 6
2009 2
2010 2
2011 2
2012 1
2013 2
2014 2
2015 2
2016 1
2017 1
2018 2
2019 2
2020 1
2021 4
2022 10
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis.
Sainz de la Maza S, Maurino J, Castillo-Triviño T, Borges M, Sebastián Torres B, Sotoca J, Alonso Torres AM, Caminero AB, Borrega L, Sánchez-Menoyo JL, Barrero-Hernández FJ, Calles C, Brieva L, Blasco MR, Dotor García-Soto J, Rodríguez-Regal A, Navarro-Cantó L, Agüera-Morales E, Garcés M, Carmona O, Gabaldón-Torres L, Forero L, Hervás M, Gómez-Ballesteros R. Sainz de la Maza S, et al. Among authors: sebastian torres b. Patient Prefer Adherence. 2023 Jun 14;17:1431-1439. doi: 10.2147/PPA.S411069. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 37337517 Free PMC article.
Clinical characteristics, respiratory management, and determinants of oxygenation in COVID-19 ARDS: A prospective cohort study.
Estenssoro E, Loudet CI, Dubin A, Kanoore Edul VS, Plotnikow G, Andrian M, Romero I, Sagardía J, Bezzi M, Mandich V, Groer C, Torres S, Orlandi C, Rubatto Birri PN, Valenti MF, Cunto E, Sáenz MG, Tiribelli N, Aphalo V, Bettini L, Ríos FG, Reina R; SATI-COVID-19 Study Group. Estenssoro E, et al. Among authors: torres s. J Crit Care. 2022 Oct;71:154021. doi: 10.1016/j.jcrc.2022.154021. Epub 2022 Mar 26. J Crit Care. 2022. PMID: 35349967 Free PMC article.
Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in mice.
Blagovic K, Smith CK, Ramakrishnan A, Moore L, Soto DR, Thompson Z, Stockmann AP, Kruszelnicki S, Thakkar A, Murray J, Torres S, Wondimagegnhu B, Yi R, Dadgar M, Paracha AM, Page C, Clear L, Chaudhry OA, Myint M, Bridgen DT, Gilbert JB, Seidl KJ, Sharei A, Loughhead S, Bernstein H, Yarar D. Blagovic K, et al. Among authors: torres s. Front Immunol. 2022 Oct 3;13:1015585. doi: 10.3389/fimmu.2022.1015585. eCollection 2022. Front Immunol. 2022. PMID: 36263022 Free PMC article.
36 results